Epizyme, Inc.
Hydrochloride salt form for EZH2 inhibition

Last updated:

Abstract:

Provided herein are novel solid forms of N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-5-(ethyl (tetrahydro-2H-pyran-4-yl)amino)-4-methyl-4'-(morpholinomethyl)-[1,1'-bip- henyl]-3-carboxamide hydrochloride, and related compositions and methods.

Status:
Grant
Type:

Utility

Filling date:

5 Jun 2018

Issue date:

14 Jul 2020